Corporate Board Profile
Tech Score: 2/100
1 mention(s) identify JOHN A. MOORE as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| SCIENTIFIC INDUSTRIES INC | 2024-04-15 | is also the Chairman of Trialogics, a clinical trial software provider. | John A. Moore is the Chairman of Trialogics, a clinical trial software provider, indicating relevant technical experience in software. |
| Filing Date | Source Excerpt |
|---|---|
| 2006-08-23 | John A. Moore has been a director and President and Chief Executive Officer of our Company since March 2006. Mr. Moore also serves as a director of Comverge. Mr. Moore is the President and founder of Edson Moore Healthcare Ventures, which he founded to acquire $150 million of drug delivery assets from Elan Pharmaceuticals in 2002. |
| 2007-11-15 | John A. Moore has been a director and President and Chief Executive Officer of our Company since March 2006. Mr. Moore also serves as a director of Comverge. Mr. Moore is the President and founder of Edson Moore Healthcare Ventures. |
| 2008-10-08 | John A. Moore has been a director and President and Chief Executive Officer of our Company since March 2006. Mr. Moore also served as a director of Comverge from March 2006 through January 2008. Mr. Moore is the President and founder of Edson Moore Healthcare Ventures, which he founded to acquire $150 million of drug delivery assets from Elan Pharmaceuticals in 2002. |
| 2009-06-22 | John A. Moore has been a director and President and Chief Executive Officer of the Company since March 2006. Mr. Moore was elected Chairman of the Board on March 25, 2009. Mr. Moore also served as a director of Comverge Inc. from March 2006 through January 2008. Mr. Moore is the President and founder of Edson Moore Healthcare Ventures, which he founded to acquire $150 million of drug delivery assets from Elan Pharmaceuticals in 2002. |
| 2010-04-28 | John A. Moore has been a director and President and Chief Executive Officer of our Company since March 2006. Mr. Moore was elected Chairman of the Board on March 25, 2009. Mr. Moore also served as a director of Comverge from March 2006 through January 2008. Mr. Moore is the President and founder of Edson Moore Healthcare Ventures, which he founded to acquire $150 million of drug delivery assets from Elan Pharmaceuticals in 2002. Mr. Moore was Chairman and EVP of ImaRx Therapeutics, a drug and medical therapy development company, from February 2004 to February 2006 and Chairman of Elite Pharmaceuticals from February 2003 to October 2004. He is currently a member of the Board of Directors of Voltaix, Inc., a leading provider of specialty gases to the solar and semiconductor industries. He was CEO of Optimer, Inc. (a research based polymer development company) from inception in 1994 until 2002 and Chairman from inception until its sale in February 2008 to Sterling Capital. |
| 2011-09-09 | John A. Moore has been a director and President and Chief Executive Officer of the Company since March 2006. Mr. Moore was elected Chairman of the Board on March 25, 2009. Mr. Moore also served as a director of our former Comverge affiliate from March 2006 through January 2008. Mr. Moore was the President and founder of Edson Moore Healthcare Ventures, which he founded to acquire $150 million of drug delivery assets from Elan Pharmaceuticals in 2002. Mr. Moore was Chairman and EVP of ImaRx Therapeutics, a drug and medical therapy development company, from February 2004 to February 2006 and Chairman of Elite Pharmaceuticals from February 2003 to October 2004. He is currently a member of the Board of Directors of Voltaix, Inc., a leading provider of specialty gases to the solar and semiconductor industries. He was CEO of Optimer, Inc. (a research based polymer development company) from inception in 1994 until 2002 and Chairman from inception until its sale in February 2008 to Sterling Capital. |
| 2012-07-26 | Mr. Moore brings his strategic vision for our Company to the Board together with his leadership and business, deal making and investor relations skills. Mr. Moore has an immense knowledge of our Company and the energy technology industry which is beneficial to the Board. |
| 2013-08-08 | Mr. Moore brings his strategic vision for our Company to the Board together with his leadership and business, deal making and investor relations skills. Mr. Moore has an immense knowledge of our Company and the energy technology industry which is beneficial to the Board. |
| 2014-08-14 | Mr. Moore has an immense knowledge of our Company and the energy technology industry which is beneficial to the Board. Mr. Moore’s service as a Director and CEO of the Company bridges a critical gap between the Company’s management and the Board. |
| 2016-02-16 | John A. Moore beneficial ownership details provided, no technical background mentioned. |
| Filing Date | Source Excerpt |
|---|---|
| 2002-01-24 | Dennis S. Aronowitz $992 $1,035 $75,000 Richard P. Chapman, Jr.* 1,035 1,080 78,100 William J. Cosgrove* 950 991 72,000 Leland O. Erdahl+ 233 244 18,000 Richard A. Farrell 950 991 72,000 Gail D. Fosler 992 1,035 75,000 William F. Glavin* 950 992 72,000 John A. Moore* 993 1,051 75,100 Patti McGill Peterson 949 991 72,000 John W. Pratt 950 991 72,000 ------ ------ --------- Totals $8,994 $9,401 $681,200 (1) The total compensation paid by the John Hancock fund complex to the Independent Trustees for the calendar year ended December 31, 2001. All the Independent Trustees are Trustees of 30 funds in the John Hancock fund complex, except for Ms. Peterson and Mr. Moore, who are trustees of 36 funds. |
| 2004-01-30 | John A. Moore+ President and Chief Executive Officer, Institute for 1996 29 (Age 64) Evaluating Health Risks (nonprofit institution) (until 2001); Chief Scientist, Science International (health Trustee research) (since 1998); Principal, Hollyhouse (consulting) (since 2000); Director, CIIT (nonprofit research) (since 2002). |
| 2005-01-21 | John A. Moore+ President and Chief Executive Officer, Institute for Evaluating 1996 49 (Age 65) Health Risks, (nonprofit institution) (until 2001); Chief Trustee Scientist, Science International (health Research) (until 2003); Principal, Hollyhouse (consulting) (since 2000); Director, CIIT (nonprofit research) (since 2002). |
| 2006-02-03 | John A. Moore+ President and Chief Executive Officer, Institute for 1996 53 (Age 66) Evaluating Health Risks, (nonprofit institution) Trustee (until 2001); Chief Scientist, Science International (health Research) (until 2003); Principal, Hollyhouse (consulting) (since 2000); Director, CIIT (nonprofit research) (since 2002). |
| 2007-02-08 | John A. Moore (1939) President and Chief Executive Officer, Institute for Evaluating Health Risks (nonprofit institution) (until 2001); Trustee since 1996; Committees: Audit and Compliance Committee, Governance Committee, Investment Performance Committee; Compensation: $1,102 for Income Securities Trust. |
| 2008-02-14 | John A. Moore (1939) Trustee. Committees: Audit and Compliance. Compensation: $1,475 (Investors Trust) + $1,535 (Income Securities Trust) = $3,010. |
| 2009-02-06 | John A. Moore (1939) Trustee 1996 President and Chief Executive Officer, Institute for Evaluating Health Risks, (nonprofit institution) (until 2001); Senior Scientist, Sciences International (health research) (until 2003); Former Assistant Administrator & Deputy Administrator, Environmental Protection Agency; Principal, Hollyhouse (consulting) (since 2000); Director, CIIT Center for Health Science Research (nonprofit research) (until 2007). Compensation: $181,000 (FYE 12-31-07) and $197,000 (FPE 10-31-08). Committees: Compliance. |
| 2009-12-02 | John A. Moore (1939) Trustee 1996 President and Chief Executive Officer, Institute for Evaluating Health Risks (nonprofit institution) (until 2001); Senior Scientist, Sciences International (health research) (until 2003); Former Assistant Administrator & Deputy Administrator, Environmental Protection Agency; Principal, Hollyhouse (consulting) (since 2000); Director, CIIT Center for Health Science Research (nonprofit research) (until 2007). 47 funds overseen. Compensation: $208,000. |
| 2010-11-24 | John A. Moore (1939) Trustee 1996 President and Chief Executive Officer, Institute for Evaluating Health Risks, (nonprofit institution) (until 2001); Senior Scientist, Sciences International (health research) (until 2003); Former Assistant Administrator & Deputy Administrator, Environmental Protection Agency; Principal, Hollyhouse (consulting) (since 2000); Director, CIIT Center for Health Science Research (nonprofit research) (until 2007). |
| 2011-11-25 | John A. Moore (1939) Trustee 1996 President and Chief Executive Officer, Institute for Evaluating Health Risks, (nonprofit institution) (until 2001); Senior Scientist, Sciences International (health research) (until 2003); Former Assistant Administrator & Deputy Administrator, Environmental Protection Agency; Principal, Hollyhouse (consulting) (since 2000); Director, CIIT Center for Health Science Research (nonprofit research) (until 2007). 47 Funds overseen. Total Compensation: $229,000. |
| Filing Date | Source Excerpt |
|---|---|
| 2002-01-24 | The Contracts/Operations Committee members are Messrs. Chapman and Moore. All members of each fund's Contracts/Operations Committee are Independent Trustees. |
| 2003-01-28 | John A. Moore President and Chief Executive Officer, Institute for 1996 39 (Age 63) Evaluating Health Risks, (nonprofit institution) Trustee (until 2001). Scientist, Science International (health Research) (since 1998); Principal, Hollyhouse (consulting) (since 2000); Director, CIIT (nonprofit research) (since 2002). ... Each Board of Trustees has an Audit Committee consisting of Messrs. Farrell, Glavin and Moore. ... Each Board of Trustees has an Administration Committee. The Administration Committee members are Ms. McGill Peterson and Messrs. Aronowitz, Chapman, Cosgrove, Farrell, Glavin, Moore and Pratt. ... The following table provides information about the compensation paid by the funds and the other investment companies in the John Hancock fund complex to the Independent Trustees for their services for the year ended December 31, 2002. ... John A. Moore* 1,088 1,138 72,000 |
| 2004-01-30 | John A. Moore+ President and Chief Executive Officer, Institute for 1996 29 (Age 64) Evaluating Health Risks (nonprofit institution) (until 2001); Chief Scientist, Science International (health Trustee research) (since 1998); Principal, Hollyhouse (consulting) (since 2000); Director, CIIT (nonprofit research) (since 2002). |
| 2005-01-21 | John A. Moore+ President and Chief Executive Officer, Institute for Evaluating 1996 49 (Age 65) Health Risks, (nonprofit institution) (until 2001); Chief Trustee Scientist, Science International (health Research) (until 2003); Principal, Hollyhouse (consulting) (since 2000); Director, CIIT (nonprofit research) (since 2002). |
| 2006-02-03 | John A. Moore+ President and Chief Executive Officer, Institute for 1996 53 (Age 66) Evaluating Health Risks, (nonprofit institution) Trustee (until 2001); Chief Scientist, Science International (health Research) (until 2003); Principal, Hollyhouse (consulting) (since 2000); Director, CIIT (nonprofit research) (since 2002). |
| 2007-02-08 | John A. Moore President and Chief Executive Officer, Institute for Evaluating Health Risks, (nonprofit institution) (until 2001); ... Trustee, John Hancock Investors Trust; Committees: Audit and Compliance Committee, Governance Committee; Compensation: $1,057 for Investors Trust, $1,102 for Income Securities Trust. |
| 2008-02-14 | John A. Moore (1939) President and Chief Executive Officer, Institute for Evaluating Health Risks (nonprofit institution) (until 2001); Senior Scientist, Sciences International (health research) (until 2003); Former Assistant Administrator, Environmental Protection Agency, Principal, Hollyhouse (consulting) (since 2000); Director, CIIT (nonprofit research) (since 2002). |
| 2009-02-06 | John A. Moore (1939) Trustee 1996 President and Chief Executive Officer, Institute for Evaluating Health Risks, (nonprofit institution) (until 2001); Senior Scientist, Sciences International (health research) (until 2003); Former Assistant Administrator & Deputy Administrator, Environmental Protection Agency; Principal, Hollyhouse (consulting) (since 2000); Director, CIIT Center for Health Science Research (nonprofit research) (until 2007). Compensation: $1,475 (FYE 12-31-07) + $5,729 (FPE 10-31-08) = $7,204 total annual compensation approximately. |
| 2009-12-02 | John A. Moore (1939) Trustee 1996 President and Chief Executive Officer, Institute for Evaluating Health Risks (nonprofit institution) (until 2001); Senior Scientist, Sciences International (health research) (until 2003); Former Assistant Administrator & Deputy Administrator, Environmental Protection Agency; Principal, Hollyhouse (consulting) (since 2000); Director, CIIT Center for Health Science Research (nonprofit research) (until 2007). 47 John Hancock Funds overseen. Compensation: $208,000. |
| 2010-11-24 | John A. Moore (1939) Trustee 1996 President and Chief Executive Officer, Institute for Evaluating Health Risks, (nonprofit institution) (until 2001); Senior Scientist, Sciences International (health research) (until 2003); Former Assistant Administrator & Deputy Administrator, Environmental Protection Agency; Principal, Hollyhouse (consulting) (since 2000); Director, CIIT Center for Health Science Research (nonprofit research) (until 2007). 47 Total Compensation All Funds in the Aggregate Compensation John Hancock Independent Trustees John A. Moore $ 210,000 |
| 2011-11-25 | John A. Moore (1939) Trustee 1996 President and Chief Executive Officer, Institute for Evaluating Health Risks, (nonprofit institution) (until 2001); Senior Scientist, Sciences International (health research) (until 2003); Former Assistant Administrator & Deputy Administrator, Environmental Protection Agency; Principal, Hollyhouse (consulting) (since 2000); Director, CIIT Center for Health Science Research (nonprofit research) (until 2007). |
| Filing Date | Source Excerpt |
|---|---|
| 2002-01-24 | President and Chief Executive Officer, Institute for Evaluating Health Risks (non-profit institution) (since September 1989); and Trustee of 36 funds managed by the Adviser. |
| 2003-01-28 | President and Chief Executive Officer, Institute for Evaluating Health Risks, (nonprofit institution) (until 2001); Senior Scientist, Sciences International (health research) (since 1998); Principal, Hollyhouse (consulting) (since 2000); Director, CIIT (nonprofit research) (since 2002). |
| 2004-01-30 | President and Chief Executive Officer, Institute for Evaluating Health Risks, (nonprofit institution) (until 2001); Chief Scientist, Sciences International (health research) (since 1998); Principal, Hollyhouse (consulting) (since 2000); Director, CIIT (nonprofit research) (since 2002). |
| 2005-01-21 | President and Chief Executive Officer, Institute for Evaluating Health Risks, (nonprofit institution) (until 2001); Chief Scientist, Sciences International (health research) (until 2003); Principal, Hollyhouse (consulting) (since 2000); Director, CIIT (nonprofit research) (since 2002). |
| 2006-02-03 | President and Chief Executive Officer, Institute for Evaluating Health Risks, (nonprofit institution) (until 2001); Chief Scientist, Sciences International (health research) (until 2003); Principal, Hollyhouse (consulting) (since 2000); Director, CIIT (nonprofit research) (since 2002). |
| 2008-02-07 | President and Chief Executive Officer, Institute for Evaluating Health Risks (nonprofit institution) (until 2001); Senior Scientist, Sciences International (health research) (until 2003); Former Assistant Administrator, Environmental Protection Agency, Principal, Hollyhouse (consulting) (since 2000); Director, CIIT (nonprofit research) (since 2002). |
| 2009-02-06 | President and Chief Executive Officer, Institute for Evaluating Health Risks; Senior Scientist, Sciences International; Former Assistant Administrator & Deputy Administrator, Environmental Protection Agency; Principal, Hollyhouse (consulting); Director, CIIT Center for Health Science Research. |
| 2010-11-24 | John A. Moore - Dr. Moore has management and operational oversight experience from his current and former positions as a senior executive of scientific research organizations and as a senior administrator of the Environmental Protection Agency. |
| 2011-11-25 | John A. Moore - Dr. Moore has management and operational oversight experience from his current and former positions as a senior executive of scientific research organizations and as a senior administrator of the Environmental Protection Agency. |
| Filing Date | Source Excerpt |
|---|---|
| 2019-12-26 | John A. Moore (age 53), a Director since January 2019 has been providing consulting services to the Company’s subsidiary, Scientific Bioprocessing, Inc. since March 2019. Mr. Moore serves as Executive Chairman of Nyrada, Inc., a drug development company since July 2019 and prior to that served as a director with Noxopharm Limited, a drug development company, and is also the Chairman of Trialogics, a clinical trial software provider. |
| 2021-01-22 | John A. Moore (age 55), a Director since January 2019 and Chairman of the Board since January 2020, is also the President of Scientific Bioprocessing, Inc. (“SBI”), a wholly owned subsidiary of the Company, since January 2020 and had been providing consulting services to SBI since March 2019. The Company has two committees – The Compensation Committee and the Audit Committee. The Audit Committee is comprised of the entire Board of Directors. |
| 2022-01-24 | John A. Moore (age 56), a Director since January 2019 and Chairman of the Board since January 2020, is also the President of SBI since January 2020 and had been providing consulting services to SBI since March 2019. ... The Company has two committees – a Compensation Committee and an Audit Committee. Both committees are comprised of the entire Board of Directors. ... For the Year Ended June 30, 2021 ... John A. Moore ... Total($) 0 |
| 2022-12-20 | John A. Moore (age 57), a Director since January 2019 and Chairman of the Board since January 2020, is also the Chairman of Scientific Bioprocessing Industries (SBI) since March 2022... John A. Moore Salary($): 180,200 Bonus($): 50,000 Total($): 237,400 |
| 2024-04-15 | is also the Chairman of Trialogics, a clinical trial software provider. |
Data sourced from SEC filings. Last updated: 2025-08-30